Published in J Neural Transm (Vienna) on December 14, 2005
Physiological roles for amyloid beta peptides. J Physiol (2006) 1.16
Neuronal AChE splice variants and their non-hydrolytic functions: redefining a target of AChE inhibitors? Br J Pharmacol (2013) 0.82
A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol (1961) 45.34
Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol (2001) 8.88
Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science (1982) 5.63
Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res (2000) 4.82
Alzheimer's disease: a disorder of cortical cholinergic innervation. Science (1983) 4.40
Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol (2002) 3.84
Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6). Neuroscience (1983) 3.26
Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends Neurosci (1989) 2.83
Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain (1976) 2.76
A histochemical method for localizing cholinesterase activity. Proc Soc Exp Biol Med (1949) 2.66
The cholinergic lesion of Alzheimer's disease: pivotal factor or side show? Learn Mem (2004) 2.35
Amnestic MCI or prodromal Alzheimer's disease? Lancet Neurol (2004) 2.29
Human memory and the cholinergic system. A relationship to aging? Arch Neurol (1974) 2.24
In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease. Neurology (1999) 1.86
Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme. Neuron (1996) 1.84
Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue. J Neurol Sci (1977) 1.83
Amyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's disease. Pharmacol Rev (2002) 1.80
Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human beta-amyloid precursor protein. Proc Natl Acad Sci U S A (1995) 1.77
Ibotenate Lesions of Hippocampus and/or Subiculum: Dissociating Components of Allocentric Spatial Learning. Eur J Neurosci (1990) 1.72
Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: observations based on the distribution of acetylcholinesterase and choline acetyltransferase. J Comp Neurol (1988) 1.54
Amyloid peptide Abeta(1-42) binds selectively and with picomolar affinity to alpha7 nicotinic acetylcholine receptors. J Neurochem (2000) 1.47
Challenging assumptions about Alzheimer's disease: mild cognitive impairment and the cholinergic hypothesis. Ann Neurol (2002) 1.45
The neuropharmacological and neurochemical basis of place learning in the Morris water maze. Brain Res Brain Res Rev (1993) 1.38
Neuron loss in key cholinergic and aminergic nuclei in Alzheimer disease: a meta-analysis. Neurobiol Aging (2002) 1.35
Age-dependent neuronal and synaptic degeneration in mice transgenic for the C terminus of the amyloid precursor protein. J Neurosci (1996) 1.25
Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients. J Neurol Sci (1982) 1.21
beta-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies. Biochem Pharmacol (2003) 1.16
The pedunculopontine nucleus in Parkinson's disease, progressive supranuclear palsy and Alzheimer's disease. J Neurol Neurosurg Psychiatry (1988) 1.15
Reorganization of cholinergic terminals in the cerebral cortex and hippocampus in transgenic mice carrying mutated presenilin-1 and amyloid precursor protein transgenes. J Neurosci (1999) 1.11
Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis. J Neurosci (2002) 1.10
Amyloid-beta deposition in skeletal muscle of transgenic mice: possible model of inclusion body myopathy. Am J Pathol (1998) 1.09
Alzheimer's disease is associated with a selective increase in alpha7 nicotinic acetylcholine receptor immunoreactivity in astrocytes. Glia (2003) 1.08
Molecular forms of acetylcholinesterase in senile dementia of Alzheimer type: selective loss of the intermediate (10S) form. Neurosci Lett (1983) 1.05
Progressive loss of cortical acetylcholinesterase activity in association with cognitive decline in Alzheimer's disease: a positron emission tomography study. Ann Neurol (2000) 1.02
Transgenic expression of human acetylcholinesterase induces progressive cognitive deterioration in mice. Curr Biol (1995) 1.02
Overexpression of the high affinity choline transporter in cortical regions affected by Alzheimer's disease. Evidence from rapid autopsy studies. J Clin Invest (1994) 1.01
Involvement of oxidative stress in the enhancement of acetylcholinesterase activity induced by amyloid beta-peptide. Neurosci Res (2003) 1.01
Cortical biopsy in Alzheimer's disease: diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations. Intraventricular Bethanecol Study Group. Ann Neurol (1992) 1.00
Place navigation in rats is impaired by lesions of medial septum and diagonal band but not nucleus basalis magnocellularis. Behav Brain Res (1988) 1.00
Acetylcholinesterase fibers and the development of senile plaques. Brain Res (1987) 0.99
Acetylcholinesterase in Alzheimer's disease. Mech Ageing Dev (2001) 0.97
Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway. Exp Neurol (2001) 0.96
High levels of circulating beta-amyloid peptide do not cause cerebral beta-amyloidosis in transgenic mice. Am J Pathol (1996) 0.95
Organization of the septal region in the rat brain: cholinergic-GABAergic interconnections and the termination of hippocampo-septal fibers. J Comp Neurol (1989) 0.95
Memory impairment and cholinergic dysfunction by centrally administered Abeta and carboxyl-terminal fragment of Alzheimer's APP in mice. FASEB J (2001) 0.92
Amyloid beta-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons. Proc Natl Acad Sci U S A (1996) 0.91
Acetylcholinesterase-positive fiber deafferentation and cell shrinkage in the septohippocampal pathway of aged amyloid precursor protein london mutant transgenic mice. Neurobiol Dis (2000) 0.91
Neuronal expression of beta-amyloid precursor protein Alzheimer mutations causes intracellular accumulation of a C-terminal fragment containing both the amyloid beta and cytoplasmic domains. J Biol Chem (1997) 0.91
The amyloid beta-protein of Alzheimer's disease increases acetylcholinesterase expression by increasing intracellular calcium in embryonal carcinoma P19 cells. J Neurochem (1997) 0.90
Impairment of cholinergic neurotransmission in adult and aged transgenic Tg2576 mouse brain expressing the Swedish mutation of human beta-amyloid precursor protein. Brain Res (2002) 0.90
Alpha7-nicotinic acetylcholine receptors mediate an Abeta(1-42)-induced increase in the level of acetylcholinesterase in primary cortical neurones. J Neurochem (2004) 0.88
The cholinergic neuronal phenotype in Alzheimer's disease. Metab Brain Dis (2000) 0.87
Acetylcholinesterase is increased in the brains of transgenic mice expressing the C-terminal fragment (CT100) of the beta-amyloid protein precursor of Alzheimer's disease. J Neurochem (1998) 0.87
Neuronal nicotinic receptor deficits in Alzheimer patients with the Swedish amyloid precursor protein 670/671 mutation. J Neurochem (1999) 0.87
Altered glycosylation of acetylcholinesterase in APP (SW) Tg2576 transgenic mice occurs prior to amyloid plaque deposition. J Neurochem (2002) 0.87
Transmitter deficits in Alzheimer's disease. Neurochem Int (1985) 0.86
Degeneration of beta-amyloid-associated cholinergic structures in transgenic APP SW mice. Brain Res (2003) 0.86
Acetylcholinesterase and its association with heparan sulphate proteoglycans in cortical amyloid deposits of Alzheimer's disease. Neuroscience (1992) 0.86
In vivo study of acetylcholine esterase in basal forebrain, amygdala, and cortex in mild to moderate Alzheimer disease. Neuroimage (2004) 0.84
Expression of nicotinic acetylcholine receptors in Alzheimer's disease: postmortem investigations and experimental approaches. Behav Brain Res (2000) 0.84
Selective neurotoxicity of COOH-terminal fragments of the beta-amyloid precursor protein. Neurosci Lett (1993) 0.83
Increased expression of intranuclear AChE involved in apoptosis of SK-N-SH cells. Neurosci Res (2002) 0.83
Acetylcholinesterase induces neuronal cell loss, astrocyte hypertrophy and behavioral deficits in mammalian hippocampus. J Neurochem (2003) 0.82
In vivo and in vitro effects of aluminum on the activity of mouse brain acetylcholinesterase. Brain Res Bull (2002) 0.82
A correlation between regional acetylcholinesterase activity in rat brain and performance in a spatial task. Behav Brain Res (1988) 0.80
Brain choline acetyltransferase and mental function in Alzheimer disease. Arch Neurol (1999) 0.80
High affinity choline transporter status in Alzheimer's disease tissue from rapid autopsy. Ann N Y Acad Sci (1996) 0.80
Transgenic mice expressing the human C99 terminal fragment of betaAPP: effects on cytochrome oxidase activity in skeletal muscle and brain. J Chem Neuroanat (2004) 0.79
The cholinergic pathology in Alzheimer's disease--discrepancies between clinical experience and pathophysiological findings. J Neural Transm (Vienna) (2002) 0.78
Ultrastructural localization of acetylcholinesterase in neurofibrillary tangles, neuropil threads and senile plaques in aged and Alzheimer's brain. Brain Res (1992) 0.78
Transgenic mice expressing the human C99 terminal fragment of betaAPP: effects on spatial learning, exploration, anxiety, and motor coordination. Exp Gerontol (2002) 0.78
Protease inhibitors and indoleamines selectively inhibit cholinesterases in the histopathologic structures of Alzheimer disease. Proc Natl Acad Sci U S A (1993) 0.78
Alz-50 immunoreactivity in the thalamic reticular nucleus in Alzheimer's disease. Brain Res (1990) 0.78
Moderate lesion of the rat cholinergic septohippocampal pathway increases hippocampal nerve growth factor synthesis: evidence for long-term compensatory changes? Brain Res Mol Brain Res (1997) 0.77
Effects of lateral and medial septal lesions on exploratory behavior in the albino rat. Brain Res (1980) 0.76
Topochemical localization of choline acetyltransferase and acetylcholinesterase in mouse brain. Brain Res (1984) 0.76
Acetylcholinesterase activity and post-lesional plasticity in the hippocampus of young and aged rats. Neuroscience (1993) 0.75
Comparative evaluation of the cytomegalovirus DNA load in polymorphonuclear leukocytes and plasma of human immunodeficiency virus-infected subjects. J Infect Dis (1998) 2.03
Structure of Marek's disease virus DNA: detailed restriction enzyme map. J Virol (1984) 2.03
Tuberculous pancreatitis. Tubercle (1990) 1.55
Expression of the late cytomegalovirus (CMV) pp150 transcript in leukocytes of AIDS patients is associated with a high viral DNA load in leukocytes and presence of CMV DNA in plasma. J Infect Dis (1999) 1.52
The structure of Marek disease virus DNA: the presence of unique expansion in nonpathogenic viral DNA. Proc Natl Acad Sci U S A (1985) 1.50
Introduction of human gamma 1 immunoglobulin genes into fertilized mouse eggs. J Biochem (1984) 1.35
SP-40,40 is a constituent of Alzheimer's amyloid. Acta Neuropathol (1992) 1.30
The economics of drug development: a grim reality and a role for clinical pharmacology. Clin Pharmacol Ther (2010) 1.29
Neurobehavioral characterization of APP23 transgenic mice with the SHIRPA primary screen. Behav Brain Res (2005) 1.20
cDNA cloning and chromosome mapping of the human Fe65 gene: interaction of the conserved cytoplasmic domains of the human beta-amyloid precursor protein and its homologues with the mouse Fe65 protein. Hum Mol Genet (1996) 1.17
Computerized testing augments pencil-and-paper tasks in measuring HIV-associated mild cognitive impairment(*). HIV Med (2011) 1.14
Exploratory activity and spatial learning in 12-month-old APP(695)SWE/co+PS1/DeltaE9 mice with amyloid plaques. Neurosci Lett (2005) 1.13
Homozygosity mapping of the Werner syndrome locus (WRN). Genomics (1994) 1.09
Spontaneous and induced mouse mutations with cerebellar dysfunctions: behavior and neurochemistry. Brain Res (2006) 1.07
Population pharmacokinetics of sildenafil in term neonates: evidence of rapid maturation of metabolic clearance in the early postnatal period. Clin Pharmacol Ther (2008) 1.07
Molecular basis of clarithromycin-resistance in Mycobacterium avium intracellulare complex. Tuber Lung Dis (2000) 1.06
Cytotoxicity mediated by conditional expression of a carboxyl-terminal derivative of the beta-amyloid precursor protein. Brain Res Mol Brain Res (1994) 1.03
Relations between open-field, elevated plus-maze, and emergence tests as displayed by C57/BL6J and BALB/c mice. J Neurosci Methods (2008) 1.02
Evaluation of the AMPLICOR cytomegalovirus test with specimens from human immunodeficiency virus-infected subjects. J Clin Microbiol (1998) 1.02
Cognitive and non-cognitive behaviors in an APPswe/PS1 bigenic model of Alzheimer's disease. Genes Brain Behav (2008) 1.01
Elevated spontaneous mutation rate in SV40-transformed Werner syndrome fibroblast cell lines. Somat Cell Mol Genet (1985) 1.00
Brain regions and genes affecting limb-clasping responses. Brain Res Rev (2011) 0.99
Neurodegenerative mechanisms in Alzheimer disease. A role for oxidative damage in amyloid beta protein precursor-mediated cell death. Mol Chem Neuropathol (1997) 0.98
Exploratory activity, anxiety, and motor coordination in bigenic APPswe + PS1/DeltaE9 mice. Neurosci Lett (2004) 0.96
Brain regions and genes affecting postural control. Prog Neurobiol (2007) 0.96
Transgenic mice expressing the betaAPP695SWE mutation: effects on exploratory activity, anxiety, and motor coordination. Brain Res (2003) 0.96
Quantitation of cytomegalovirus (CMV) DNA in leukocytes of human immunodeficiency virus-infected subjects with and without CMV disease by using PCR and the SHARP Signal Detection System. J Clin Microbiol (1997) 0.95
Human herpesvirus 8 DNA load in leukocytes of human immunodeficiency virus-infected subjects: correlation with the presence of Kaposi's sarcoma and response to anticytomegalovirus therapy. Antimicrob Agents Chemother (1999) 0.94
Population pharmacokinetics of clinafloxacin in healthy volunteers and patients with infections: experience with heterogeneous pharmacokinetic data. Clin Pharmacokinet (2001) 0.94
Changes in immunological and virological parameters in HIV-1 infected subjects following leukapheresis. J Clin Apher (2003) 0.94
Amantadine hydrochloride treatment in heredodegenerative ataxias: a double blind study. J Neurol Neurosurg Psychiatry (1996) 0.93
Neurobehavioral evaluation of lurcher mutant mice during ontogeny. Brain Res Dev Brain Res (1997) 0.92
Masked prosthetic graft to sigmoid colon fistula diagnosed by 18-fluorodeoxyglucose positron emission tomography. Eur J Vasc Endovasc Surg (2006) 0.91
Discrimination learning in Rora(sg) and Grid2(ho) mutant mice. Neurobiol Learn Mem (2008) 0.91
Impaired regional fatty acid uptake and systolic dysfunction in hypertrophied right ventricle. J Nucl Med (1998) 0.90
Analysis of c-myc DNA amplification in non-small cell lung carcinoma in comparison with small cell lung carcinoma using polymerase chain reaction. Clin Exp Med (2001) 0.90
Sympathetic reinnervation demonstrated on serial iodine-123-metaiodobenzylguanidine SPECT images after cardiac transplantation. J Nucl Med (1998) 0.90
The future is now: model-based clinical trial design for Alzheimer's disease. Clin Pharmacol Ther (2014) 0.89
APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD). Neurosci Biobehav Rev (2012) 0.89
Expression of human immunodeficiency virus type 1 in the nervous system of transgenic mice leads to neurological disease. J Virol (1994) 0.89
Comparison of dual-isotope acquisition of 201Tl and 99Tcm-tetrofosmin for the detection of ischaemic heart disease and determination of the optimal imaging time of 99Tcm-tetrofosmin. Nucl Med Commun (1998) 0.89
Concurrent chemotherapy and intensity-modulated radiation therapy for anal carcinoma--clinical outcomes in a large National Cancer Institute-designated integrated cancer centre network. Clin Oncol (R Coll Radiol) (2011) 0.89
Spatial learning and exploration of environmental stimuli in 24-month-old female APP23 transgenic mice with the Swedish mutation. Brain Res (2004) 0.88
Emergence and prevalence of cytomegalovirus UL97 mutations associated with ganciclovir resistance in AIDS patients. AIDS (1998) 0.88
Impaired motor skills on static and mobile beams in lurcher mutant mice. Exp Brain Res (1997) 0.88
Event-related potentials for category-specific information during passive viewing of faces and objects. Int J Neurosci (2001) 0.88
Spatial learning, exploration, anxiety, and motor coordination in female APP23 transgenic mice with the Swedish mutation. Brain Res (2002) 0.88
Neurobehavioral characteristics of mice with modified intermediate filament genes. Rev Neurosci (2003) 0.88
Clindamycin with primaquine vs. Trimethoprim-sulfamethoxazole therapy for mild and moderately severe Pneumocystis carinii pneumonia in patients with AIDS: a multicenter, double-blind, randomized trial (CTN 004). CTN-PCP Study Group. Clin Infect Dis (1998) 0.88
Molecular analysis of the Cip1/Waf1 (p21) gene in diverse types of human tumors. Biochim Biophys Acta (1995) 0.87
Increased bone mineral turnover without increased glucose utilization in sclerotic and hyperplastic change in fibrous dysplasia. Ann Nucl Med (1998) 0.86
The effects of cerebellar damage on maze learning in animals. Cerebellum (2003) 0.86
Comparisons between C57BL/6J and A/J mice in motor activity and coordination, hole-poking, and spatial learning. Brain Res Bull (2002) 0.86
An unexpected role of the cerebellum: involvement in nutritional organization. Physiol Behav (1993) 0.86
Effects of a B-vitamin-deficient diet on exploratory activity, motor coordination, and spatial learning in young adult Balb/c mice. Brain Res (2007) 0.85
Iodine-123-iomazenil and iodine-123-iodoamphetamine SPECT in major cerebral artery occlusive disease. J Nucl Med (1998) 0.85
Intrathoracic mass simulated by ectopic kidney. Clin Nucl Med (2000) 0.85
Trypanosoma cruzi: correlation of resistance and susceptibility in infected bred mice with the in vivo primary antibody response to sheep red blood cells. Exp Parasitol (1981) 0.85
The effects of a mild stressor on spontaneous alternation in mice. Behav Brain Res (2001) 0.85
Effects of ventrolateral-ventromedial thalamic lesions on motor coordination and spatial orientation in rats. Neurosci Res (2003) 0.85
Early development of synchronized walking on the rotorod in rats. Effects of training and handling. Behav Brain Res (1998) 0.85
The effects of unilateral removal of the cerebellar hemispheres on motor functions and weight gain in rats. Brain Res (2002) 0.84
Fluorine-18-fluorodeoxyglucose PET identification of cardiac metastasis arising from uterine cervical carcinoma. J Nucl Med (1998) 0.84
Motor coordination, exploration, and spatial learning in a natural mouse mutation (nervous) with Purkinje cell degeneration. Behav Genet (2003) 0.84
Polymorphic tetranucleotide repeat site within intron 7 of the beta-amyloid precursor protein gene and its lack of association with Alzheimer's disease. Hum Genet (1998) 0.84
Effects of midline and lateral cerebellar lesions on motor coordination and spatial orientation. Brain Res (1996) 0.84
Brain regions and genes affecting myoclonus in animals. Neurosci Res (2012) 0.83
Sensorimotor learning and retention during equilibrium tests in Purkinje cell degeneration mutant mice. Brain Res (1997) 0.83
Motor abnormalities in weaver mutant mice. Exp Brain Res (1987) 0.83
Regional brain distribution of noradrenaline uptake sites, and of alpha1-alpha2- and beta-adrenergic receptors in PCD mutant mice: a quantitative autoradiographic study. Neuroscience (1999) 0.82
Levels of DNA damage are unaltered in mice overexpressing human catalase in nuclei. Free Radic Biol Med (2000) 0.82
Heterodimerization of Bcl-2 and Bcl-X(L) with Bax and Bad in colorectal cancer. Acta Oncol (2000) 0.82
Map location of homologous regions between Marek's disease virus and herpesvirus of turkey and the absence of detectable homology in the putative tumor-inducing gene. J Virol (1985) 0.82
Heat shock-enhanced T cell apoptosis with heat shock protein 70 on T cell surface in multicentric Castleman's disease. Clin Exp Immunol (1996) 0.82
The structure of Marek's disease virus DNA: amplification of repeat sequence in IRs and TRs. Microbiol Immunol (1988) 0.81
Mice with the deleted neurofilament of low molecular weight (Nefl) gene: 2. Effects on motor functions and spatial orientation. J Neurosci Res (2005) 0.81
[Comparison between the succinate dehydrogenase inhibition test and ATP assay for in vitro chemosensitivity testing]. Gan To Kagaku Ryoho (1987) 0.81
Transgenic mice expressing the PS1-A246E mutation: effects on spatial learning, exploration, anxiety, and motor coordination. Behav Brain Res (2003) 0.81
Distribution of gastrin in canine, cat, and human digestive organs. Am J Surg (1976) 0.81
Human cytomegalovirus glycoprotein B genotypes in blood of AIDS patients: lack of association with either the viral DNA load in leukocytes or presence of retinitis. J Med Virol (1999) 0.81
Apoptosis of T cells in multicentric Castleman's disease. Clin Immunol Immunopathol (1996) 0.81
Distribution of dopamine transporters in basal ganglia of cerebellar ataxic mice by [125I]RTI-121 quantitative autoradiography. Neurochem Int (1998) 0.81
Accumulation of spermidine/spermine N1-acetyltransferase and alternatively spliced mRNAs as a delayed response of HeLa S3 cells following X-ray irradiation. Int J Radiat Biol (2004) 0.81
The effect of an oral administration of Lactobacillus casei strain shirota on azoxymethane-induced colonic aberrant crypt foci and colon cancer in the rat. Oncol Rep (2000) 0.81
Induction of DNA fragmentation by tannin- and lignin-related substances. Anticancer Res (1996) 0.81
Effects of dentate nucleus lesions on spatial and postural sensorimotor learning in rats. Behav Brain Res (2001) 0.81
Effects of electrolytic lesions of the lateral pallidum on motor coordination, spatial learning, and regional brain variations of cytochrome oxidase activity in rats. Behav Brain Res (1999) 0.81
Motor coordination in mice with hotfoot, Lurcher, and double mutations of the Grid2 gene encoding the delta-2 excitatory amino acid receptor. Physiol Behav (2003) 0.80
Amantadine hydrochloride treatment in olivopontocerebellar atrophy: a long-term follow-up study. Eur Neurol (1999) 0.80
Treadmill performance of mice with cerebellar lesions: 2. Lurcher mutant mice. Neurobiol Learn Mem (2000) 0.80
Effects of centrolateral or medial thalamic lesions on motor coordination and spatial orientation in rats. Neurosci Res (2000) 0.80
Regional brain evaluation of acetylcholinesterase activity in PS1/A246E transgenic mice. Neurosci Res (2008) 0.80